2019
DOI: 10.1016/j.cryobiol.2019.02.004
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of five additives to mitigate toxicity of cryoprotective agents on porcine chondrocytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
7
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 14 publications
(7 citation statements)
references
References 59 publications
0
7
0
Order By: Relevance
“…19 Additives such as chondroitin sulfate, ascorbic acid, or glucosamine have been shown to improve porcine chondrocyte survival after exposure to a high molarity CPA cocktail solution. 20 Therefore, we present the vitrification of intact porcine femoral condyles using an optimized approach based on an established 7-hour protocol. Our aim is to develop a successful protocol for long-term storage of intact femoral allografts via vitrification for clinical repair of articular cartilage defects.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…19 Additives such as chondroitin sulfate, ascorbic acid, or glucosamine have been shown to improve porcine chondrocyte survival after exposure to a high molarity CPA cocktail solution. 20 Therefore, we present the vitrification of intact porcine femoral condyles using an optimized approach based on an established 7-hour protocol. Our aim is to develop a successful protocol for long-term storage of intact femoral allografts via vitrification for clinical repair of articular cartilage defects.…”
Section: Introductionmentioning
confidence: 99%
“… 19 Additives such as chondroitin sulfate, ascorbic acid, or glucosamine have been shown to improve porcine chondrocyte survival after exposure to a high molarity CPA cocktail solution. 20 …”
Section: Introductionmentioning
confidence: 99%
“…Notably, we have previously demonstrated that AA provides significant chondroprotection to AC during cryoprotectant exposure/removal and during short-term hypothermic storage. [25][26][27][28][29] We have also shown that using clinical grade AA (i.e., the pharmaceutical equivalent of this additive) provided similar chondroprotective effects to chondrocytes when compared with research grade AA, allowing our research group to translate AA supplementation into vitrification protocols intended for human cartilage. 27 More recently, our group developed a 2-step, dual-temperature, multi-cryoprotectant loading protocol that successfully vitrified AC cubes (pig and human) and showed that the cartilage maintained high cell viability and metabolic function immediately after vitrification and re-warming.…”
Section: Introductionmentioning
confidence: 94%
“…16,18,25 We have investigated the inclusion of supplemental additive compounds as a means to reduce CPA toxicity by mitigating oxidative stress. [26][27][28][29] Various antioxidant compounds such as chondroitin sulfate or ascorbic acid (AA) have been evaluated for their ability to protect cartilage during high exposure to CPA. Notably, we have previously demonstrated that AA provides significant chondroprotection to AC during cryoprotectant exposure/removal and during short-term hypothermic storage.…”
Section: Introductionmentioning
confidence: 99%
“…[4,9] Literature also states that incubation of cells/tissue in additives, such as ascorbic acid, glucosamine, chondroitin sulfate or their inclusion in cryo-preservative media reduces cryoprotectant toxicity induced cellular injury thereby improving cell viability on retrieval. [11,12] Till date, there are no reports on the membrane function of cryopreserved chondrocytes, comparing them with freshly isolated cells. One of the methods to assess membrane function is to study its ion channel population and their characteristics.…”
Section: Introductionmentioning
confidence: 99%